[go: up one dir, main page]

PL377106A1 - Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent - Google Patents

Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent

Info

Publication number
PL377106A1
PL377106A1 PL377106A PL37710603A PL377106A1 PL 377106 A1 PL377106 A1 PL 377106A1 PL 377106 A PL377106 A PL 377106A PL 37710603 A PL37710603 A PL 37710603A PL 377106 A1 PL377106 A1 PL 377106A1
Authority
PL
Poland
Prior art keywords
depigmenting
adapalene
skin
composition
agent
Prior art date
Application number
PL377106A
Other languages
Polish (pl)
Inventor
Isabelle Pelisson
Andre Jomard
Original Assignee
Galderma Research & Development, S.N.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research & Development, S.N.C. filed Critical Galderma Research & Development, S.N.C.
Publication of PL377106A1 publication Critical patent/PL377106A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Topically applicable skin depigmenting compositions, suited for treatment of such hyperpigmentary disorders as melasma and chloasma, contain a thus effective amount of at least one skin depigmenting active agent, for example hydroquinone or 4-hydroxyanisole, in admixture with a depigmentation-accelerating amount of adapalene (6-[3-(1-adamantyl)-4-methoxyphenyl]-2-napthanoic acid), and optionally with at least one sunscreen, formulated into a topically applicable, physiologically acceptable medium therefor.
PL377106A 2002-09-05 2003-09-01 Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent PL377106A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0211022 2002-09-05
US41135002P 2002-09-18 2002-09-18

Publications (1)

Publication Number Publication Date
PL377106A1 true PL377106A1 (en) 2006-01-23

Family

ID=31979939

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377106A PL377106A1 (en) 2002-09-05 2003-09-01 Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent

Country Status (19)

Country Link
US (1) US20050163731A1 (en)
EP (1) EP1536763B1 (en)
JP (1) JP4662769B2 (en)
KR (1) KR20050057238A (en)
CN (1) CN100391432C (en)
AT (1) ATE366566T1 (en)
AU (1) AU2003270272B2 (en)
BR (1) BR0313370B1 (en)
CA (1) CA2495043A1 (en)
CY (1) CY1107732T1 (en)
DE (1) DE60314887T2 (en)
DK (1) DK1536763T3 (en)
ES (1) ES2289315T3 (en)
MX (1) MXPA05002064A (en)
PL (1) PL377106A1 (en)
PT (1) PT1536763E (en)
RU (1) RU2317066C2 (en)
WO (1) WO2004021967A2 (en)
ZA (1) ZA200501753B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7544674B2 (en) 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
PL374779A1 (en) * 2002-12-12 2005-10-31 Galderma Research & Development, S.N.C. A water-alcohol discoloring gel containing a phenolic derivative and a retinoid
FR2871377B1 (en) * 2004-06-11 2007-08-24 Galderma Res & Dev HYDRO-ALCOHOLIC DEPIGMENTING GEL COMPRISING MEQUINOL AND ADAPALENE
FR2890314B1 (en) * 2005-09-02 2009-03-20 Galderma Res & Dev SKIN POWDER COMPOSITION COMPRISING ADAPALENE AT LEAST ONE DEPIGMENTING AGENT AND AT LEAST ONE ANTI-INFLAMMATORY AGENT
WO2007052157A2 (en) * 2005-09-02 2007-05-10 Galderma Research & Development Depigmenting composition for the skin, comprising adapalene, at least one depigmenting agent and at least one anti-inflammatory agent
FR2894820B1 (en) * 2005-12-15 2008-02-29 Galderma Res & Dev COMPOSITIONS COMPRISING AT LEAST ONE RETINOID COMPOUND AND AT LEAST ONE ANTI-IRRITANT COMPOUND AND USES THEREOF
FR2910321B1 (en) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc CREAM GEL COMPRISING AT LEAST ONE RETINOID AND BENZOLE PEROXIDE
FR2910320B1 (en) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc EMULSION COMPRISING AT LEAST ONE RETINOID AND BENZOLE PEROXIDE
JP5646129B2 (en) * 2007-03-31 2014-12-24 大正製薬株式会社 Adapalene-containing external preparation composition
FR2915682B1 (en) * 2007-05-04 2009-07-03 Galderma Res & Dev DERMATOLOGICAL AND COSMETIC DEPIGMENTING COMPOSITIONS, PROCESSES FOR THEIR PREPARATION, AND USES THEREOF
US9364424B2 (en) * 2007-11-19 2016-06-14 Stiefel Laboratories, Inc. Topical cosmetic skin lightening compositions and methods of use thereof
FR2931663B1 (en) * 2008-05-30 2010-07-30 Galderma Res & Dev NOVEL ANHYDROUS DEPIGMENTING COMPOSITIONS COMPRISING A SOLUBILIZED PHENOLIC DERIVATIVE.
FR2931661B1 (en) * 2008-05-30 2010-07-30 Galderma Res & Dev NOVEL DEPIGMENTING COMPOSITIONS IN THE FORM OF AN ANHYDROUS VASELIN - FREE AND ELASTOMER - FREE COMPOSITION COMPRISING A SOLUBILIZED PHENOLIC DERIVATIVE AND A RETINOID.
FR2949065B1 (en) 2009-08-17 2011-10-21 Natura Cosmeticos Sa SKIN LIGHTENING COMPLEX, USE OF SAID COMPLEX, COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING SAID COMPLEX AND METHOD FOR APPLICATION THEREOF
CA2796412A1 (en) * 2010-04-29 2011-11-03 Galderma Research & Development Method for treating scars with adapalene 0.3%
FR2969492B1 (en) * 2010-12-23 2013-07-05 Galderma Res & Dev DERMATOLOGICAL FOAMS OBTAINED FROM GEL OR SUSPENSION CONTAINING ADAPALENE
RU2450836C1 (en) * 2011-03-15 2012-05-20 Закрытое акционерное общество Фармацевтическое научно-производственное предприятие "Ретиноиды" Combined ointment composition for reducing intensity of local skin hyperpigmentation
GB2568758A (en) * 2017-11-28 2019-05-29 Chitty Nicholas Sun protection and acne treatment and prevention composition
US12133907B2 (en) * 2021-01-07 2024-11-05 Actera Ingredients, Inc. Lipophilic third generation retinoid

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856934A (en) * 1970-06-24 1974-12-24 A Kligman Skin depigmentation
US5194247A (en) * 1989-08-24 1993-03-16 Xina Nair Synergistic skin depigmentation composition
FR2653336B1 (en) * 1989-10-20 1994-04-08 Oreal PHARMACEUTICAL COMPOSITION AND DEPIGMENTANT COSMETICS BASED ON CAFEIC ACID.
US5395611A (en) * 1990-04-24 1995-03-07 The Governors Of The University Of Alberta Phenolic amine depigmenting and antimelanoma agents
FR2714601B1 (en) * 1993-12-30 1996-02-09 Oreal Depigmenting composition for the simultaneous treatment of surface and deep layers, its use.
US6068834A (en) * 1994-03-04 2000-05-30 The Procter & Gamble Company Skin lightening compositions
FR2723315B1 (en) * 1994-08-02 1996-10-25 Cird Galderma METHOD AND COMPOSITION FOR STIMULATING DIFFERENTIATION OF PREADIPOCYTE CELLS AND RELATED THERAPEUTIC TREATMENTS
FR2752734B1 (en) * 1996-09-02 1998-11-06 Cird Galderma USE OF RETINOIDS FOR THE PREPARATION OF A MEDICAMENT FOR TREATING CONDITIONS RELATED TO VEGF OVEREXPRESSION
JP2000516643A (en) * 1998-05-07 2000-12-12 ザ、プロクター、エンド、ギャンブル、カンパニー Composition containing ascorbic acid compound
CA2382022A1 (en) * 1999-08-24 2001-03-01 The Procter & Gamble Company Methods of lightening keratinous tissue by topical application of oxime compound containing compositions
US20030077301A1 (en) * 1999-12-16 2003-04-24 Maibach Howard I. Topical pharmaceutical composition for the treatment of inflammatory dermatoses
US20030147977A1 (en) * 2000-05-03 2003-08-07 Goodman David S. Topical preparation for treating acne and hirsutism
US6358541B1 (en) * 2000-05-03 2002-03-19 David S. Goodman Topical preparation for the treatment of hair loss
EP1317425B1 (en) * 2000-09-11 2004-11-03 Pfizer Products Inc. Resorcinol derivatives
US7189759B2 (en) * 2001-05-23 2007-03-13 Medicis Pharmaceutical Corporation Compositions for the treatment of pigmentation disorders and methods for their manufacture
US20030003142A1 (en) * 2001-05-23 2003-01-02 Wortzman Mitchell S. Composition and method for the treatment of pigmentation disorders

Also Published As

Publication number Publication date
RU2005109553A (en) 2005-08-20
EP1536763B1 (en) 2007-07-11
DE60314887T2 (en) 2008-03-13
CY1107732T1 (en) 2013-04-18
ZA200501753B (en) 2007-01-31
AU2003270272B2 (en) 2008-06-19
RU2317066C2 (en) 2008-02-20
JP4662769B2 (en) 2011-03-30
PT1536763E (en) 2007-08-20
US20050163731A1 (en) 2005-07-28
KR20050057238A (en) 2005-06-16
CA2495043A1 (en) 2004-03-18
EP1536763A2 (en) 2005-06-08
WO2004021967A3 (en) 2005-02-17
BR0313370B1 (en) 2015-02-24
MXPA05002064A (en) 2005-06-08
CN100391432C (en) 2008-06-04
AU2003270272A1 (en) 2004-03-29
ES2289315T3 (en) 2008-02-01
DE60314887D1 (en) 2007-08-23
JP2006511466A (en) 2006-04-06
WO2004021967A2 (en) 2004-03-18
DK1536763T3 (en) 2007-11-05
ATE366566T1 (en) 2007-08-15
BR0313370A (en) 2006-04-18
CN1681473A (en) 2005-10-12

Similar Documents

Publication Publication Date Title
CY1107732T1 (en) DISINFECTION COMPOSITION FOR INCLUSIVE HANDLER LEATHER AND AN EFFECTIVE DISINFECTION FACTOR
AR049829A1 (en) PROCEDURE AND USEFUL COMPOSITIONS TO PREVENT AND / OR TREAT SENSITIVE AND / OR DRY SKIN
WO2007002831A3 (en) Topical skin treating compostions
EP2444060A3 (en) Composition
ATE311844T1 (en) NON-IRRITANT COMPOSITION FOR TREATING ACNE AND OTHER SKIN CONDITIONS
AU7371600A (en) Use of alpha-linolenic acid metabolites for treatment or prevention of cancer
GB9918025D0 (en) Skin care composition
GR1003530B (en) Fast dissolving composition having analgesic activity
TW200740427A (en) Highly bioavailable oral delayed release dosage forms of O-desmethylvenlafaxine succinate
DE69415018D1 (en) LIQUID LIQUID PREPARATION TO BE ORALED CONTAINING 2- (4-ISOBUTYLPHENYL) PROPIONIC ACID
MXPA03005510A (en) Compositions and methods for treating hyperpigmentation.
WO2002009679A3 (en) Use of 13-cis retinoic acid for the treatment of emphysema
WO2000002593A3 (en) Cleansing and treating lotion for treating comedones
WO2007065289A3 (en) 4-oxo-(iso)tretinoin for the topical treatment of severe dermatological disorders
DE60135927D1 (en) Nd
CA2433343A1 (en) Cosmetic compositions containing rosemary extract and dha
WO2002017956A3 (en) Stabilized fgf formulations containing reducing agents
WO2003070180A3 (en) Compositions and methods for delivery of skin cosmeceuticals
ATE459336T1 (en) FORMULATION FOR DERMAL USE
WO2001022917A3 (en) Effervescent compositions comprising nimesulide
AU2003250001A1 (en) Use of compositions comprising benzoyl peroxide and glycyrrhetinic acid for the treatment of acne
AR030647A1 (en) PHARMACEUTICAL COMPOSITION WITH SPECIFIC WATER ACTIVITY
GR3034803T3 (en) Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets
WO2001060781A3 (en) Diphenyl compounds, formulations and uses thereof
AR041145A1 (en) DEPIGMENTING COMPOSITION OF SKIN THAT INCLUDES ADAPALENE AND AT LEAST A DEPIGMENTING AGENT

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)